Summary
The wild type NIH strain of herpes simplex virus type 1 (HSV-1) has a mixed plaque morphology of both large and small plaques. From this virus we selected a large plaque isolate that was a high producer of thymidine kinase (TK) activity (designated TK+) and a small plaque isolate that produced 25 per cent of the TK activity of the large plaque mutant (designated TK 1/4). A TK− mutant of the large plaque virus was obtained after passage of the virus in the presence of BUdR. The pathogenicity of the TK 1/4 virus strain in relation to the TK+ and TK− strains was investigated in mice after inoculation of the virus into the eyes by corneal scarification. The TK+ strain was highly pathogenic, caused encephalitis and killed most of the mice, whereas the TK− strain did not cause latent infections in the trigeminal ganglia or kill the mice. The TK 1/4 virus strain replicated in the eyes within 24 hours after inoculation and entered the trigeminal ganglia, establishing a latent infection in almost all of the mice. By increasing the infectious dose tenfold, the TK 1/4 virus caused an active infection in the trigeminal ganglia (ganglionitis), migrated to the brain, and killed the mice. The results indicate that not only is a low level of TK required to establish latent infections in mice, but also the degree of virulence is determined by the amount of TK produced by the infecting virus.
Similar content being viewed by others
References
Centifanto-Fitzgerald, N. M., Yamaguchi, T., Kaufman, H. E., Tognon, M., Roizman, B.: Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA. J. exp. Med.155, 475–489 (1982).
Dasgupta, U. B., Summers, W. C.: Ultraviolet reactivation of herpes simplex virus is mutagenic and inducible in mammalian cells. Proc. Natl. Acad. Sci. U.S.A.75, 2378–2381 (1978).
Field, H. J. Darby, G.: Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovirin vitro andin vivo. Antimicrob. Agents Chemother.17, 209–216 (1980).
Field, H. J., Wildy, P.: The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J. Hyg. (Cambridge)81, 267–277 (1978).
Iwatsuki, N., Okazaki, R.: Mechanism of regulation of deoxythymidine kinase ofEscherichia coli. II. Effect of temperature on the enzyme activity and kinetics. J. mol. Biol.29, 155–165 (1967).
Klein, R. J., Friedman-Kien, A. E., DeStefano, E.: Pathogenesis of experimental skin infections induced by drug-resistant herpes simplex virus mutants. Infect. Immun.34, 693–701 (1981).
Locker, H., Frenkel, N.: Bam I, Kpn I and Sal I restriction enzyme maps of the DNAs of herpes simplex virus strains Justin and F: Occurrence of heterogeneities in defined regions of the viral DNA. J. Virol.32, 429–441 (1979).
Marcialis, M. A. La Colla, P., Schivo, M. L., Flore, O., Firinu, A. Loddo, B.: Low virulence and immunogenicity in mice and in rabbits of variants of herpes simplex virus resistant to 5-iodo-2-deoxyuridine. Experientia31, 502–503 (1975).
Okazaki, R., Kornberg, A.: Deoxythimidine kinase ofEscherichia coli. II. Kinetics and feedback control. J. biol. Chem.239, 275–284 (1964).
Pavan-Langston, D., Park, N. H., Lass, J. H.: Herpetic ganglionic latency. Acyclovir and vidarabine therapy. Arch. Ophthalmol.97, 1508–1510 (1979).
Price, R. W., Kahn, A.: Resistance of peripheral autonomic neurons toin vivo productive infection by herpes simplex virus mutants deficient of TK activity. Infec. Immun.34, 571–580 (1981).
Shlomai, J., Friedmann, A., Becker, Y.: Replicative intermediates of herpes simplex virus DNA. Virology69, 647–659 (1976).
Tenser, R. B., Dunstan, M. E.: Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion. Virology99, 417–422 (1979).
Tenser, R. B., Miller, R. L., Rapp, F.: Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus. Science205, 915–917 (1979).
Tenser, R. B., Ressel, S., Dunstan, M. E.: Herpes simplex virus thymidine kinase expression in trigeminal ganglion infection: correlation of enzyme activity with ganglion virus titer and evidence ofin vivo complementation. Virology112, 328–341 (1981).
Wigler, M., Silverstein, S., Lee, L.-S., Pellicer, A., Cheng, Y.-C., Axel, R.: Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell11, 223–232 (1977).
Wigler, M., Sweet, R., Sim, G. K., Wold, B., Pellicer, A., Lacy, E., Maniatis, T., Silverstein, S., Axel, R.: Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell16, 777–785 (1979).
Author information
Authors and Affiliations
Additional information
With 6 Figures
Rights and permissions
About this article
Cite this article
Gordon, Y., Gilden, D.H., Shtram, Y. et al. A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice. Archives of Virology 76, 39–49 (1983). https://doi.org/10.1007/BF01315702
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01315702